{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:12:06Z","timestamp":1758820326054},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.semnephrol.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T19:37:55Z","timestamp":1533325075000},"page":"346-354","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Precision Medicine and Personalized Approach to Renal Transplantation"],"prefix":"10.1016","volume":"38","author":[{"given":"Donald C.","family":"Dafoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekamol","family":"Tantisattamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uttam","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2018.05.005_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"1","author":"Laupacis","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1681\/ASN.V123589","article-title":"Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates","volume":"3","author":"Ojo","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","volume":"5","author":"Lentine","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5500\/wjt.v6.i1.135","article-title":"Kidney transplantation in obese patients","volume":"1","author":"Tran","year":"2016","journal-title":"World J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trre.2016.12.002","article-title":"Management of the obese kidney transplant candidate","volume":"1","author":"Lesage","year":"2017","journal-title":"Transplant Rev (Orlando)."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/tri.12205","article-title":"Pretransplant identification of acute rejection risk following kidney transplantation","volume":"2","author":"Lebranchu","year":"2014","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sethi","year":"2017","journal-title":"J Immunol Res."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0008","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2215\/CJN.06720810","article-title":"Posttransplant recurrence of primary glomerulonephritis","volume":"12","author":"Ponticelli","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0009","doi-asserted-by":"crossref","first-page":"e5419","DOI":"10.1097\/MD.0000000000005419","article-title":"Living donor renal transplantation in patients with antiphospholipid syndrome: a case report","volume":"46","author":"Choi","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s00125-014-3353-2","article-title":"In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone","volume":"11","author":"Lindahl","year":"2014","journal-title":"Diabetologia."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0011","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00125-006-0463-5","article-title":"Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients","volume":"12","author":"Giannarelli","year":"2006","journal-title":"Diabetologia."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0012","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00467-013-2659-5","article-title":"Transplantation tolerance","volume":"12","author":"Salisbury","year":"2014","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MOT.0000000000000463","article-title":"Xenotransplantation: past, present, and future","volume":"6","author":"Ekser","year":"2017","journal-title":"Curr Opin Organ Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0014","first-page":"93","article-title":"Regenerative medicine in organ and tissue transplantation: shortly and practically achievable?","volume":"3","author":"Heidary Rouchi","year":"2015","journal-title":"Int J Organ Transplant Med."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.TP.0000128638.85491.76","article-title":"A systematic review of laparoscopic live-donor nephrectomy","volume":"3","author":"Tooher","year":"2004","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0016","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/j.1600-6143.2006.01567.x","article-title":"Psychosocial health of living kidney donors: a systematic review","volume":"12","author":"Clemens","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0017","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/tri.12974","article-title":"Psychosocial wellbeing after living kidney donation - a longitudinal, prospective study","volume":"10","author":"Maple","year":"2017","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0018","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"6","author":"Muzaale","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0019","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1097\/TP.0000000000001838","article-title":"Advanced donation programs and deceased donor-initiated chains-2 innovations in kidney paired donation","volume":"12","author":"Wall","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.294.21.2726","article-title":"Deceased-donor characteristics and the survival benefit of kidney transplantation","volume":"21","author":"Merion","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0021","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archsurg.2011.267","article-title":"Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience","volume":"11","author":"Lonze","year":"2011","journal-title":"Arch Surg."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0022","unstructured":"OPTN\/UNOS Ad Hoc Disease Transmission Advisory Committee. Briefing paper guidance on explaining risk related to use of U.S. PHS increased risk donor organs when considering organ offers. 2017. p. 1-19."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0023","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/ajt.13260","article-title":"Transplanting kidneys from deceased donors with severe acute kidney injury","volume":"8","author":"Heilman","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ki.2015.88","article-title":"Kidney donation after circulatory death (DCD): state of the art","volume":"2","author":"Summers","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/ajt.13968","article-title":"Local expansion of donation after circulatory death kidney transplant activity improves waitlisted outcomes and addresses inequities of access to transplantation","volume":"2","author":"Mirshekar-Syahkal","year":"2017","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0026","unstructured":"2017 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5500\/wjt.v5.i2.38","article-title":"Changing organ allocation policy for kidney transplantation in the United States","volume":"2","author":"Chopra","year":"2015","journal-title":"World J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0028","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1432-2277.2009.00970.x","article-title":"`When good kidneys pump badly': outcomes of deceased donor renal allografts with poor pulsatile perfusion characteristics","volume":"4","author":"Guarrera","year":"2010","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802289","article-title":"Machine perfusion or cold storage in deceased-donor kidney transplantation","volume":"1","author":"Moers","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trre.2016.02.002","article-title":"Immunological risk assessment: the key to individualized immunosuppression after kidney transplantation","volume":"2","author":"Pratschke","year":"2016","journal-title":"Transplant Rev (Orlando)."},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2018.05.005_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 annual data report: kidney","volume":"15","author":"Matas","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0032","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"19","author":"Brennan","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trre.2016.10.006","article-title":"Immunosuppression for kidney transplantation: where are we now and where are we going?","volume":"1","author":"Lim","year":"2017","journal-title":"Transplant Rev (Orlando)."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"2","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/TP.0b013e31825c1d6c","article-title":"Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial","volume":"5","author":"Kramer","year":"2012","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0036","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"4","author":"Woodle","year":"2008","journal-title":"Ann Surg."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0037","doi-asserted-by":"crossref","first-page":"333ra349","DOI":"10.1126\/scitranslmed.aac5954","article-title":"Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform","volume":"8","author":"Zarrinpar","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0038","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1117-1244","article-title":"Predictable response: finding optimal drugs and doses using artificial intelligence","volume":"11","author":"Chakradhar","year":"2017","journal-title":"Nat Med."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0039","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(04)70087-2","article-title":"Racial variation in dosage requirements of tacrolimus","volume":"348","author":"Andrews","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group","volume":"4","author":"Neylan","year":"1998","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0041","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1067\/mcp.2001.113183","article-title":"The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups","volume":"1","author":"Mancinelli","year":"2001","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0042","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1399-0012.2002.01103.x","article-title":"The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring","volume":"4","author":"Felipe","year":"2002","journal-title":"Clin Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0043","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00008571-200107000-00008","article-title":"Identification and functional characterization of eight CYP3A4 protein variants","volume":"5","author":"Eiselt","year":"2001","journal-title":"Pharmacogenetics."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0044","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/tpj.2015.87","article-title":"Genotype-guided tacrolimus dosing in African-American kidney transplant recipients","volume":"1","author":"Sanghavi","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0045","doi-asserted-by":"crossref","first-page":"81285","DOI":"10.18632\/oncotarget.18150","article-title":"Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients","volume":"46","author":"Qu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0046","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/507337","article-title":"Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies","volume":"7","author":"Small","year":"2006","journal-title":"Clin Infect Dis."},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2018.05.005_bib0047","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"2","author":"Sawinski","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0049","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/bmt.2012.215","article-title":"BK virus-associated bilateral ureteric stenosis after haematopoietic SCT: viral kinetics and successful treatment","volume":"5","author":"Hwang","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clinmicnews.2016.07.002","article-title":"Monitoring for viral infections in transplant patients","volume":"16","author":"Miller","year":"2016","journal-title":"Clin Microbiol News."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0051","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/ctr.12201","article-title":"Delayed allograft inflammation following alemtuzumab induction for kidney transplantation","volume":"5","author":"Heilman","year":"2013","journal-title":"Clin Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/193724","article-title":"Antibody-mediated rejection in kidney transplantation: a review","volume":"2012","author":"Puttarajappa","year":"2012","journal-title":"J Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0053","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MOT.0000000000000128","article-title":"Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches","volume":"6","author":"Jordan","year":"2014","journal-title":"Curr Opin Organ Transplant."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0054","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/tri.12207","article-title":"Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations","volume":"1","author":"Dieplinger","year":"2014","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/TP.0000000000001321","article-title":"Establishing biomarkers in transplant medicine: a critical review of current approaches","volume":"10","author":"Anglicheau","year":"2016","journal-title":"Transplantation."},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.05.005_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant."}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T22:52:00Z","timestamp":1720479120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929518300652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0270929518300652"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.005","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision Medicine and Personalized Approach to Renal Transplantation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}